Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in women needs more research and better management strategies.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Body and beard hair can be used for hair restoration in severely bald patients, but the technique is complex and costly.

Hair restoration surgery techniques have evolved, with focus on patient selection and realistic goals, and future advancements may include cloning and gene therapy.

COVID-19 may trigger sudden temporary hair loss.

Successful eyebrow restoration can be done using careful hair transplant techniques and choosing the right patients.

Hair transplantation successfully treated hair loss in a patient with Trichorhinophalangeal syndrome.

Female pattern hair loss is common, worsens with age, and requires long-term treatment to manage.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Woolly hair is a rare genetic condition with no effective treatments.

Hair product allergies are common, especially to hair dyes, and hairdressers are at higher risk.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

Male hair loss is mainly due to thinner hair, not less hair.

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

Early diagnosis and personalized treatment are crucial for managing Female Pattern Hair Loss in women.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.